These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Somatostatin receptor imaging: a new horizon in the diagnostic management of neuroblastoma. Sautter-Bihl ML; Dörr U; Schilling F; Treuner J; Bihl H Semin Oncol; 1994 Oct; 21(5 Suppl 13):38-41. PubMed ID: 7992079 [No Abstract] [Full Text] [Related]
15. Effect of chemotherapy on somatostatin receptor detection with octreotide scintigraphy in hormone-refractory prostate cancer patients. Mencobonii M; Tredici S; Rebella L; Bergaglio M; Galbusera V; Manzara A; Claudiani F; Malcangi B; Varaldo M Anticancer Res; 2006; 26(3B):2233-5. PubMed ID: 16821593 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas. Robben JH; Visser-Wisselaar HA; Rutteman GR; van Rijk PP; van Dongen AJ; Voorhout G; van den Ingh TS; Hofland LJ; Lamberts SW J Nucl Med; 1997 Jul; 38(7):1036-42. PubMed ID: 9225787 [TBL] [Abstract][Full Text] [Related]
17. What is a false-positive somatostatin receptor scintigraphy? Reubi JC J Nucl Med; 1998 Dec; 39(12):2193-4. PubMed ID: 9867170 [No Abstract] [Full Text] [Related]
18. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Reubi JC; Waser B; van Hagen M; Lamberts SW; Krenning EP; Gebbers JO; Laissue JA Int J Cancer; 1992 Apr; 50(6):895-900. PubMed ID: 1348240 [TBL] [Abstract][Full Text] [Related]